Caris Life Sciences Inc
Veridion Score
Composite trend over time
Why is CAI moving today?
Caris Life Sciences Inc is a patient-centric, next-generation AI TechBio company. It develop and commercialize solutions to transform healthcare through the use of comprehensive molecular information and artificial intelligence/machine learning algorithms at scale.
Real vendor fields plus Veridion-computed history. Missing fields stay blank.
Warehouse intelligence for CAI.
CAI insider activity
Caris Life Sciences Inc
3 insiders bought in the last 90 days
Net selling: -$11.4M across loaded Form 4 rows.
Loaded official disclosures do not show all three sources aligned on this ticker.
| Filing date | Trade date | Insider | Title | Type | Price | Qty | Owned | Value | Receipt |
|---|---|---|---|---|---|---|---|---|---|
| 2026-06-02 | 2026-05-29 | Knowles Jonathan Kenneth Charles | Insider | buy | $15.62 | 1,600 | 308,979 | $25K | SEC Form 4 |
| 2026-06-02 | 2026-05-29 | POSTE GEORGE | Insider | buy | $15.62 | 1,600 | 17,729 | $25K | SEC Form 4 |
| 2026-05-18 | 2026-05-15 | Power Luke Thomas | Insider | sell | $15.25 | 9,771 | 153,771 | $149K | SEC Form 4 |
| 2026-05-18 | 2026-05-15 | Brille Brian J | Insider | sell | $15.25 | 13,987 | 230,303 | $213K | SEC Form 4 |
| 2026-05-18 | 2026-05-15 | Spetzler David Baxley | Insider | sell | $15.25 | 13,856 | 530,083 | $211K | SEC Form 4 |
Showing 5 recent rows. Sovereign unlocks 26 additional rows, full sorting, and the named-filer history.
Upgrade to Sovereign · $25/moCAI contract awards, year to date.
Public federal awards linked to this ticker.
CAI lobbying filings, year to date.
Registered lobbying filings matched to Caris Life Sciences Inc.